{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:40:38Z","timestamp":1792712438821,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02362288"],"award-info":[{"award-number":["RF-2016-02362288"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5x1000 RC2019"],"award-info":[{"award-number":["5x1000 RC2019"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21073"],"award-info":[{"award-number":["21073"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Identification of somatic mutations in key oncogenes in melanoma is important to lead the effective and efficient use of personalized anticancer treatment. Conventional methods focus on few genes per run and, therefore, are unable to screen for multiple genes simultaneously. The use of Next-Generation Sequencing (NGS) technologies enables sequencing of multiple cancer-driving genes in a single assay, with reduced costs and DNA quantity needed and increased mutation detection sensitivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We designed a customized IMI somatic gene panel for targeted sequencing of actionable melanoma mutations; this panel was tested on three different NGS platforms using 11 metastatic melanoma tissue samples in blinded manner between two EMQN quality certificated laboratory.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The detection limit of our assay was set-up to a Variant Allele Frequency (VAF) of 10% with a coverage of at least 200x. All somatic variants detected by all NGS platforms with a VAF\u2009\u2265\u200910%, were also validated by an independent method. The IMI panel achieved a very good concordance among the three NGS platforms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study demonstrated that, using the main sequencing platforms currently available in the diagnostic setting, the IMI panel can be adopted among different centers providing comparable results.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-020-01052-5","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T15:03:32Z","timestamp":1607958212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)"],"prefix":"10.1186","volume":"15","author":[{"name":"Italian Association for Cancer Research (AIRC) Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Vanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Italian Melanoma Intergroup (IMI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Casula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Manca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Dalmasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Colombino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica Teresa","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Rozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Paliogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ghiorzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"issue":"1","key":"1052_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21387.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1052_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"1052_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat J-P, et al. A landscape of driver mutations in melanoma. Cell. 2012;150:251\u201363. https:\/\/doi.org\/10.1016\/j.cell.2012.06.024.","journal-title":"Cell"},{"key":"1052_CR4","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ng.2359","volume":"44","author":"M Krauthammer","year":"2012","unstructured":"Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012;44:1006\u201314. https:\/\/doi.org\/10.1038\/ng.2359.","journal-title":"Nat Genet"},{"issue":"7","key":"1052_CR5","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","unstructured":"Cancer Genome Atlas Network. Genomic classification of cutaneous melanoma. Cell. 2015;161(7):1681\u201396. https:\/\/doi.org\/10.1016\/j.cell.2015.05.044.","journal-title":"Cell."},{"issue":"7653","key":"1052_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, et al. Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545(7653):175\u201380. https:\/\/doi.org\/10.1038\/nature22071.","journal-title":"Nature."},{"issue":"4","key":"1052_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.6004\/jnccn.2019.0018","volume":"17","author":"DG Coit","year":"2019","unstructured":"Coit DG, Thompson JA, Albertini MR, Barker C, Carson WE, Contreras C, et al. Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2019;17(4):367\u2013402. https:\/\/doi.org\/10.6004\/jnccn.2019.0018.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"7359","key":"1052_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nature10275","volume":"476","author":"AH Berger","year":"2011","unstructured":"Berger AH, Knudson AG, Pandolfi PP. A continuum model for tumour suppression. Nature. 2011;476(7359):163\u20139. https:\/\/doi.org\/10.1038\/nature10275.","journal-title":"Nature."},{"issue":"3","key":"1052_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/path.4204","volume":"230","author":"SJ Furney","year":"2013","unstructured":"Furney SJ, Turajlic S, Stamp G, Nohadani M, Carlisle A, Thomas JM, et al. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol. 2013;230(3):261\u20139. https:\/\/doi.org\/10.1002\/path.4204.","journal-title":"J Pathol"},{"issue":"5","key":"1052_CR10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/pcmr.12279","volume":"27","author":"SJ Furney","year":"2014","unstructured":"Furney SJ, Turajlic S, Stamp G, Thomas JM, Hayes A, Strauss D, et al. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Pigment Cell Melanoma Res. 2014;27(5):835\u20138. https:\/\/doi.org\/10.1111\/pcmr.12279.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4","key":"1052_CR11","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.18632\/oncotarget.6614","volume":"7","author":"P Johansson","year":"2016","unstructured":"Johansson P, Aoude LG, Wadt K, Glasson WJ, Warrier SK, Hewitt AW, et al. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. Oncotarget. 2016;7(4):4624\u201331. https:\/\/doi.org\/10.18632\/oncotarget.6614.","journal-title":"Oncotarget"},{"issue":"3","key":"1052_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/CMR.0000000000000345","volume":"27","author":"JD Hintzsche","year":"2017","unstructured":"Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, et al. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma. Version 2. Melanoma Res. 2017;27(3):189\u201399. https:\/\/doi.org\/10.1097\/CMR.0000000000000345.","journal-title":"Melanoma Res"},{"issue":"3","key":"1052_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/path.5017","volume":"244","author":"J Lyu","year":"2018","unstructured":"Lyu J, Song Z, Chen J, Shepard MJ, Song H, Ren G, et al. Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets. J Pathol. 2018;244(3):358\u201366. https:\/\/doi.org\/10.1002\/path.5017.","journal-title":"J Pathol"},{"issue":"11","key":"1052_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11912-018-0733-7","volume":"20","author":"G Palmieri","year":"2018","unstructured":"Palmieri G, Colombino M, Casula M, Manca A, Mandal\u00e0 M, Cossu A. Italian Melanoma Intergroup (IMI). Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches. Curr Oncol Rep. 2018;20(11):86. https:\/\/doi.org\/10.1007\/s11912-018-0733-7.","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"1052_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/ijc.31791","volume":"144","author":"JS Wilmott","year":"2019","unstructured":"Wilmott JS, Johansson PA, Newell F, Waddell N, Ferguson P, Quek C, et al. Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility. Int J Cancer. 2019;144(5):1049\u201360. https:\/\/doi.org\/10.1002\/ijc.31791.","journal-title":"Int J Cancer"},{"issue":"12","key":"1052_CR16","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1158\/1078-0432.CCR-18-3442","volume":"25","author":"R Zhou","year":"2019","unstructured":"Zhou R, Shi C, Tao W, Li J, Wu J, Han Y, et al. Analysis of mucosal melanoma whole-genome landscapes reveals clinically relevant genomic aberrations. Clin Cancer Res. 2019;25(12):3548\u201360. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3442.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1052_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jmoldx.2015.02.004","volume":"17","author":"PJ Lamy","year":"2015","unstructured":"Lamy PJ, Castan F, Lozano N, Mont\u00e9lion C, Audran P, Bibeau F, et al. Next-generation genotyping by digital PCR to detect and quantify the BRAF V600E mutation in melanoma biopsies. J Mol Diagn. 2015;17(4):366\u201373. https:\/\/doi.org\/10.1016\/j.jmoldx.2015.02.004.","journal-title":"J Mol Diagn."},{"issue":"4","key":"1052_CR18","doi-asserted-by":"publisher","first-page":"e0153576","DOI":"10.1371\/journal.pone.0153576","volume":"11","author":"A Harl\u00e9","year":"2016","unstructured":"Harl\u00e9 A, Salleron J, Franczak C, Dubois C, Filhine-Tressarieu P, Leroux A, et al. Detection of BRAF mutations using a fully automated platform and comparison with high resolution melting, real-time allele specific amplification, immunohistochemistry and next generation sequencing assays, for patients with metastatic melanoma. PLoS One. 2016;11(4):e0153576. https:\/\/doi.org\/10.1371\/journal.pone.0153576.","journal-title":"PLoS One"},{"issue":"5","key":"1052_CR19","doi-asserted-by":"publisher","first-page":"8069","DOI":"10.18632\/oncotarget.14094","volume":"8","author":"W Bruno","year":"2017","unstructured":"Bruno W, Martinuzzi C, Andreotti V, Pastorino L, Spagnolo F, Dalmasso B, et al. Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry. Oncotarget. 2017;8(5):8069\u201382. https:\/\/doi.org\/10.18632\/oncotarget.14094.","journal-title":"Oncotarget"},{"issue":"2","key":"1052_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40291-017-0258-z","volume":"21","author":"C Franczak","year":"2017","unstructured":"Franczak C, Salleron J, Dubois C, Filhine-Tr\u00e9sarrieu P, Leroux A, Merlin JL, et al. Comparison of five different assays for the detection of BRAF mutations in formalin-fixed paraffin embedded tissues of patients with metastatic melanoma. Mol Diagn Ther. 2017;21(2):209\u201316. https:\/\/doi.org\/10.1007\/s40291-017-0258-z.","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"1052_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.prp.2017.01.010","volume":"213","author":"E Sener","year":"2017","unstructured":"Sener E, Yildirim P, Tan A, Gokoz O, Tezel GG. Investigation of BRAF mutation analysis with different technical platforms in metastatic melanoma. Pathol Res Pract. 2017;213(5):522\u201330. https:\/\/doi.org\/10.1016\/j.prp.2017.01.010.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"1052_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/modpathol.2017.104","volume":"31","author":"L Cheng","year":"2018","unstructured":"Cheng L, Lopez-Beltran A, Massari F, MacLennan GT, Montironi R. Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine. Mod Pathol. 2018;31(1):24\u201338. https:\/\/doi.org\/10.1038\/modpathol.2017.104.","journal-title":"Mod Pathol"},{"issue":"11","key":"1052_CR23","first-page":"3773","volume":"10","author":"B Malicherova","year":"2018","unstructured":"Malicherova B, Burjanivova T, Grendar M, Minarikova E, Bobrovska M, Vanova B, et al. Droplet digital PCR for detection of BRAF V600E mutation in formalin-fixed, paraffin-embedded melanoma tissues: a comparison with Cobas\u00ae 4800, sanger sequencing, and allele-specific PCR. Am J Transl Res. 2018;10(11):3773\u201381.","journal-title":"Am J Transl Res"},{"issue":"2","key":"1052_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jmoldx.2017.11.009","volume":"20","author":"AC McEvoy","year":"2018","unstructured":"McEvoy AC, Wood BA, Ardakani NM, Pereira MR, Pearce R, Cowell L, et al. Droplet digital PCR for mutation detection in formalin-fixed, paraffin-embedded melanoma tissues: a comparison with sanger sequencing and pyrosequencing. J Mol Diagn. 2018;20(2):240\u201352. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.11.009.","journal-title":"J Mol Diagn"},{"key":"1052_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/1471-2407-14-519","volume":"14","author":"J Marchant","year":"2014","unstructured":"Marchant J, Mange A, Larrieux M, Costes V, Solassol J. Comparative evaluation of the new FDA approved THxID\u2122-BRAF test with high resolution melting and sanger sequencing. BMC Cancer. 2014;14:519. https:\/\/doi.org\/10.1186\/1471-2407-14-519.","journal-title":"BMC Cancer"},{"key":"1052_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/OTT.S39096","volume":"8","author":"F Spagnolo","year":"2015","unstructured":"Spagnolo F, Ghiorzo P, Orgiano L, Pastorino L, Picasso V, Tornari E, et al. BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. Onco Targets Ther. 2015;8:157\u201368. https:\/\/doi.org\/10.2147\/OTT.S39096.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"1052_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s12020-015-0720-9","volume":"53","author":"C Martinuzzi","year":"2016","unstructured":"Martinuzzi C, Pastorino L, Andreotti V, Garuti A, Minuto M, Fiocca R, et al. A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer. Endocrine. 2016;53(3):672\u201380. https:\/\/doi.org\/10.1007\/s12020-015-0720-9.","journal-title":"Endocrine."},{"issue":"3","key":"1052_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","volume":"19","author":"LJ Jennings","year":"2017","unstructured":"Jennings LJ, Arcila ME, Corless C, Kamel-Reid S, Lubin IM, Pfeifer J, et al. Guidelines for validation of next-generation sequencing-based oncology panels: a joint consensus recommendation of the Association for Molecular Pathology and College of American pathologists. J Mol Diagn. 2017;19(3):341\u201365. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.01.011.","journal-title":"J Mol Diagn."},{"issue":"3","key":"1052_CR29","doi-asserted-by":"publisher","first-page":"a003707","DOI":"10.1101\/mcs.a003707","volume":"5","author":"Y Akkari","year":"2019","unstructured":"Akkari Y, Smith T, Westfall J, Lupo S. Implementation of cancer next-generation sequencing testing in a community hospital. Cold Spring Harb Mol Case Stud. 2019;5(3):a003707. https:\/\/doi.org\/10.1101\/mcs.a003707.","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"1","key":"1052_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12967-019-2039-4","volume":"17","author":"A Manca","year":"2019","unstructured":"Manca A, Paliogiannis P, Colombino M, Casula M, Lissia A, Botti G, et al. Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach. J Transl Med. 2019;17(1):289. https:\/\/doi.org\/10.1186\/s12967-019-2039-4.","journal-title":"J Transl Med"},{"issue":"1","key":"1052_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24\u20136. https:\/\/doi.org\/10.1038\/nbt.1754.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1052_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2466\/pr0.1966.19.1.3","volume":"19","author":"JJ Bartko","year":"1966","unstructured":"Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep. 1966;19(1):3\u201311. https:\/\/doi.org\/10.2466\/pr0.1966.19.1.3.","journal-title":"Psychol Rep"},{"key":"1052_CR33","unstructured":"Gamer M. Lemon J. Fellows I. Singh P. Irr: various coefficients of interrater reliability and agreement. R Package Version 0.84.1. 2019. Available at: https:\/\/CRAN.R-project.org\/package=irr."},{"key":"1052_CR34","volume-title":"R Foundation for statistical computing","author":"R Core Team","year":"2019","unstructured":"Core Team R. R: a language and environment for statistical computing. In: R Foundation for statistical computing. Vienna: Austria. URL; 2019. https:\/\/www.R-project.org\/."},{"issue":"4","key":"1052_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/PAP.0b013e3182977199","volume":"20","author":"ES Williams","year":"2013","unstructured":"Williams ES, Hegde M. Implementing genomic medicine in pathology. Adv Anat Pathol. 2013;20(4):238\u201344. https:\/\/doi.org\/10.1097\/PAP.0b013e3182977199.","journal-title":"Adv Anat Pathol"},{"key":"1052_CR36","doi-asserted-by":"publisher","first-page":"251364","DOI":"10.1155\/2012\/251364","volume":"2012","author":"L Liu","year":"2012","unstructured":"Liu L, Li Y, Li S, Hu N, He Y, Pong R, et al. Comparison of next-generation sequencing systems. J Biomed Biotechnol. 2012;2012:251364. https:\/\/doi.org\/10.1155\/2012\/251364.","journal-title":"J Biomed Biotechnol"},{"key":"1052_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/1471-2164-13-341","volume":"13","author":"MA Quail","year":"2012","unstructured":"Quail MA, Smith M, Coupland P, Otto TD, Harris SR, Connor TR, et al. A tale of three next generation sequencing platforms: comparison of ion torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics. 2012;13:341. https:\/\/doi.org\/10.1186\/1471-2164-13-341.","journal-title":"BMC Genomics"},{"issue":"5","key":"1052_CR38","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/gb-2013-14-5-r51","volume":"14","author":"MG Ross","year":"2013","unstructured":"Ross MG, Russ C, Costello M, Hollinger A, Lennon NJ, Hegarty R, et al. Characterizing and measuring bias in sequence data. Genome Biol. 2013;14(5):R51. https:\/\/doi.org\/10.1186\/gb-2013-14-5-r51.","journal-title":"Genome Biol"},{"issue":"5","key":"1052_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00439-016-1656-8","volume":"135","author":"E Damiati","year":"2016","unstructured":"Damiati E, Borsani G, Giacopuzzi E. Amplicon-based semiconductor sequencing of human exomes: performance evaluation and optimization strategies. Hum Genet. 2016;135(5):499\u2013511. https:\/\/doi.org\/10.1007\/s00439-016-1656-8.","journal-title":"Hum Genet"},{"issue":"5","key":"1052_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/dnares\/dsz017","volume":"26","author":"MP Sato","year":"2019","unstructured":"Sato MP, Ogura Y, Nakamura K, Nishida R, Gotoh Y, Hayashi M, et al. Comparison of the sequencing bias of currently available library preparation kits for Illumina sequencing of bacterial genomes and metagenomes. DNA Res. 2019;26(5):391\u20138. https:\/\/doi.org\/10.1093\/dnares\/dsz017.","journal-title":"DNA Res"},{"issue":"4","key":"1052_CR41","doi-asserted-by":"publisher","first-page":"e1003031","DOI":"10.1371\/journal.pcbi.1003031","volume":"9","author":"LM Bragg","year":"2013","unstructured":"Bragg LM, Stone G, Butler MK, Hugenholtz P, Tyson GW. Shining a light on dark sequencing: characterising errors in ion torrent PGM data. PLoS Comput Biol. 2013;9(4):e1003031. https:\/\/doi.org\/10.1371\/journal.pcbi.1003031.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"1052_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/bib\/bbv029","volume":"17","author":"D Laehnemann","year":"2016","unstructured":"Laehnemann D, Borkhardt A, McHardy AC. Denoising DNA deep sequencing data-high-throughput sequencing errors and their correction. Brief Bioinform. 2016;17(1):154\u201379. https:\/\/doi.org\/10.1093\/bib\/bbv029.","journal-title":"Brief Bioinform"},{"key":"1052_CR43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.5858\/arpa.2014-0250-CP","volume":"139","author":"N Aziz","year":"2015","unstructured":"Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, et al. College of American Pathologists\u2019 laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med. 2015;139:481\u201393. https:\/\/doi.org\/10.5858\/arpa.2014-0250-CP.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"1052_CR44","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564\u20139. https:\/\/doi.org\/10.1002\/humu.22981.","journal-title":"Hum Mutat"},{"issue":"1","key":"1052_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ejhg.2015.226","volume":"24","author":"G Matthijs","year":"2016","unstructured":"Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, et al. Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet. 2016;24(1):2\u20135. https:\/\/doi.org\/10.1038\/ejhg.2015.226 Epub 2015 Oct 28. Erratum in: Eur J Hum Genet. 2016 Oct;24(10):1515.","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"1052_CR46","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/jmedgenet-2019-106152","volume":"56","author":"S Hume","year":"2019","unstructured":"Hume S, Nelson TN, Speevak M, McCready E, Agatep R, Feilotter H, et al. CCMG practice guideline: laboratory guidelines for next-generation sequencing. J Med Genet. 2019;56(12):792\u2013800. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106152.","journal-title":"J Med Genet"},{"issue":"10","key":"1052_CR47","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/bioinformatics\/btv009","volume":"31","author":"HA Shihab","year":"2015","unstructured":"Shihab HA, Rogers MF, Gough J, Mort M, Cooper DN, Day IN, et al. An integrative approach to predicting the functional effects of non-coding and coding sequence variation. Bioinformatics. 2015;31(10):1536\u201343. https:\/\/doi.org\/10.1093\/bioinformatics\/btv009.","journal-title":"Bioinformatics."},{"issue":"7","key":"1052_CR48","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1101\/gr.3577405","volume":"15","author":"GM Cooper","year":"2005","unstructured":"Cooper GM, Stone EA. Asimenos G; NISC comparative sequencing program, green ED, Batzoglou S, et al. distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005;15(7):901\u201313. https:\/\/doi.org\/10.1101\/gr.3577405.","journal-title":"Genome Res"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01052-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-020-01052-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01052-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T15:05:36Z","timestamp":1607958336000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-020-01052-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1052"],"URL":"https:\/\/doi.org\/10.1186\/s13000-020-01052-5","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"17 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients were informed about the use of their tumour tissues samples for mutation analyses, gave permission to collect tissue specimens for such purposes and signed a written consent. The study was approved by local Ethics Committees of the institution involved in this study (National Research Council and Ospedale Policlinico San Martino).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}